170 related articles for article (PubMed ID: 38243702)
1. Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations.
Acharya M; Hayes CJ; Li C; Painter JT; Dayer L; Martin BC
Pain Med; 2024 Mar; 25(3):173-186. PubMed ID: 38243702
[TBL] [Abstract][Full Text] [Related]
2. Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients.
Acharya M; Hayes CJ; Li C; Painter JT; Dayer L; Martin BC
Clin J Pain; 2023 Mar; 39(3):107-118. PubMed ID: 36728675
[TBL] [Abstract][Full Text] [Related]
3. Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas.
Acharya M; Hayes CJ; Li C; Painter JT; Dayer L; Martin BC
Curr Med Res Opin; 2022 Nov; 38(11):1947-1957. PubMed ID: 36000252
[TBL] [Abstract][Full Text] [Related]
4. Impact of Hydrocodone Rescheduling on Dental Prescribing of Opioids.
Yan CH; Hubbard CC; Lee TA; Sharp LK; Evans CT; Calip GS; Rowan SA; McGregor JC; Gellad WF; Suda KJ
JDR Clin Trans Res; 2023 Oct; 8(4):402-412. PubMed ID: 35708454
[TBL] [Abstract][Full Text] [Related]
5. Provider specialty and odds of a new codeine, hydrocodone, oxycodone and tramadol prescription before and after the CDC opioid prescribing guideline publication.
Tucker J; Salas J; Zhang Z; Grucza R; Scherrer JF
Prev Med; 2021 May; 146():106466. PubMed ID: 33636196
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention's Opioid Prescribing Guidelines.
Scherrer JF; Tucker J; Salas J; Zhang Z; Grucza R
JAMA Netw Open; 2020 Dec; 3(12):e2027481. PubMed ID: 33263762
[TBL] [Abstract][Full Text] [Related]
8. Opioid-Induced Esophageal Dysfunction: Differential Effects of Type and Dose.
Snyder DL; Crowell MD; Horsley-Silva J; Ravi K; Lacy BE; Vela MF
Am J Gastroenterol; 2019 Sep; 114(9):1464-1469. PubMed ID: 31403963
[TBL] [Abstract][Full Text] [Related]
9. Commonly Initiated Opioids and Risk of Fracture Hospitalizations in United States Nursing Homes.
Hunnicutt JN; Hume AL; Liu SH; Ulbricht CM; Tjia J; Lapane KL
Drugs Aging; 2018 Oct; 35(10):925-936. PubMed ID: 30187291
[TBL] [Abstract][Full Text] [Related]
10. A retrospective analysis of the impact of Michigan's opioid prescribing legislation on discharge opioid prescribing at a single institution.
Sadowski R; Hillaker E; Chavarria M; Khaliq F; Schwark A
J Opioid Manag; 2022; 18(5):467-474. PubMed ID: 36226786
[TBL] [Abstract][Full Text] [Related]
11. Patterns in opioid prescription in the United States by region and prescribers over a 4-year period.
Bigal LM; Bibeau K; Dumbar S
J Opioid Manag; 2019; 15(6):499-506. PubMed ID: 31850512
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of opioid prescribing after rescheduling of hydrocodone-containing products.
Bernhardt MB; Taylor RS; Hagan JL; Patel N; Chumpitazi CE; Fox KA; Glover C
Am J Health Syst Pharm; 2017 Dec; 74(24):2046-2053. PubMed ID: 29222361
[TBL] [Abstract][Full Text] [Related]
13. Chronic use of tramadol after acute pain episode: cohort study.
Thiels CA; Habermann EB; Hooten WM; Jeffery MM
BMJ; 2019 May; 365():l1849. PubMed ID: 31088782
[TBL] [Abstract][Full Text] [Related]
14. Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone.
Ben-Joseph R; Bell JA; Brixner D; Kansal A; Paramore C; Chitnis A; Holly P; S Burgoyne D
J Manag Care Spec Pharm; 2016 Apr; 22(4):358-66. PubMed ID: 27023689
[TBL] [Abstract][Full Text] [Related]
15. Individual short-acting opioids and the risk of opioid-related adverse events in adolescents.
Chung CP; Callahan ST; Cooper WO; Dupont WD; Murray KT; Franklin AD; Hall K; Dudley JA; Stein CM; Ray WA
Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1448-1456. PubMed ID: 31418512
[TBL] [Abstract][Full Text] [Related]
16. Tramadol Provides Similar Pain Relief and a Better Side Effect Profile than Oxycodone (or Hydrocodone) Alone or in Combination With Tramadol After Anterior Cruciate Ligament Reconstruction or Arthroscopic Knee Debridement.
Hazzard S; McLaughlin A; Cacace H; Nukala V; Asnis P
Arthrosc Sports Med Rehabil; 2023 Jun; 5(3):e765-e771. PubMed ID: 37388889
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Increased Hydrocodone Regulation on Opioid Prescribing in an Urban Safety-Net Health Care System.
Northrup TF; Carroll K; Suchting R; Villarreal YR; Zare M; Stotts AL
J Am Board Fam Med; 2019; 32(3):362-374. PubMed ID: 31068400
[TBL] [Abstract][Full Text] [Related]
18. New depression diagnosis following prescription of codeine, hydrocodone or oxycodone.
Scherrer JF; Salas J; Bucholz KK; Schneider FD; Burroughs T; Copeland LA; Sullivan MD; Lustman PJ
Pharmacoepidemiol Drug Saf; 2016 May; 25(5):560-8. PubMed ID: 27004714
[TBL] [Abstract][Full Text] [Related]
19. Effect size comparison of ketorolac nasal spray and commonly prescribed oral combination opioids for pain relief after third molar extraction surgery.
Niebler G; Dayno J
Postgrad Med; 2016 Jan; 128(1):12-7. PubMed ID: 26616001
[TBL] [Abstract][Full Text] [Related]
20. The effect of a more strict 2014 DEA schedule designation for hydrocodone products on opioid prescription rates in the United States.
Harrison ML; Walsh TL
Clin Toxicol (Phila); 2019 Nov; 57(11):1064-1072. PubMed ID: 30789065
[No Abstract] [Full Text] [Related]
[Next] [New Search]
